Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Cerundolo

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
The Journal of Experimental Medicine|September 1, 1989
Interaction of lymphokine-activated killer cells with susceptible targets does not induce second messenger generation and cytolytic granule exocytosisP Zanovello, A Rosato, V Bronte, et al.
International Journal of Cancer|April 13, 2000
Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cellsA Mackensen, B Herbst, J L Chen, et al.
Cancer Research|May 8, 1999
An antigen-targeted approach to adoptive transfer therapy of cancerD Valmori, M J Pittet, D Rimoldi, et al.
Nature Medicine|July 4, 2001
Apoptotic cells overexpress vinculin and induce vinculin-specific cytotoxic T-cell cross-primingA Propato, G Cutrona, V Francavilla, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 1999
Cutting edge: rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanomaP R Dunbar, J L Chen, D Chao, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2000
Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogueD Valmori, F Lévy, I Miconnet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2000
Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patientsD Valmori, V Dutoit, D Liénard, et al.
European Journal of Immunology|June 26, 1999
CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patientsD E Speiser, D Valmori, D Rimoldi, et al.
Cancer Research|August 27, 1999
Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376D Valmori, M J Pittet, C Vonarbourg, et al.
AIDS Research and Human Retroviruses|August 4, 2001
Effects of retroviral protease inhibitors on proteasome function and processing of HIV-derived MHC class I-restricted cytotoxic T lymphocyte epitopesA D Kelleher, B L Booth, A K Sewell, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
The Journal of Experimental Medicine|September 1, 1989
Interaction of lymphokine-activated killer cells with susceptible targets does not induce second messenger generation and cytolytic granule exocytosisP Zanovello, A Rosato, V Bronte, et al.
International Journal of Cancer|April 13, 2000
Phase I study in melanoma patients of a vaccine with peptide-pulsed dendritic cells generated in vitro from CD34(+) hematopoietic progenitor cellsA Mackensen, B Herbst, J L Chen, et al.
Cancer Research|May 8, 1999
An antigen-targeted approach to adoptive transfer therapy of cancerD Valmori, M J Pittet, D Rimoldi, et al.
Nature Medicine|July 4, 2001
Apoptotic cells overexpress vinculin and induce vinculin-specific cytotoxic T-cell cross-primingA Propato, G Cutrona, V Francavilla, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 1999
Cutting edge: rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanomaP R Dunbar, J L Chen, D Chao, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2000
Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogueD Valmori, F Lévy, I Miconnet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 22, 2000
Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patientsD Valmori, V Dutoit, D Liénard, et al.
European Journal of Immunology|June 26, 1999
CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patientsD E Speiser, D Valmori, D Rimoldi, et al.
Cancer Research|August 27, 1999
Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376D Valmori, M J Pittet, C Vonarbourg, et al.
AIDS Research and Human Retroviruses|August 4, 2001
Effects of retroviral protease inhibitors on proteasome function and processing of HIV-derived MHC class I-restricted cytotoxic T lymphocyte epitopesA D Kelleher, B L Booth, A K Sewell, et al.
Pageof 10